News
08-13-2008, 09:12 AM
Scientists in the UK and Finland have discovered that a new combination of the chemotherapy drug doxorubicin and the bone-protecting drug zoledronic acid, both of which are considerably cheaper than herceptin, stopped breast cancer tumors growing in mice. Experts suggest that since both drugs are already in use, and if the combination proves effective and safe in human clinical trials, it should not take as long for it to be available as a new treatment for patients.
More... (http://www.medicalnewstoday.com/articles/118157.php)
More... (http://www.medicalnewstoday.com/articles/118157.php)